Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adriamycin therapy for advanced ovarian carcinoma recurrent after chemotherapy.

× No keyword cloud information.

12 in total

1. A phase II study of oral idarubicin in advanced recurrent or refractory ovarian carcinoma.

Authors: C J Williams
Journal: Cancer Chemother Pharmacol Date: 1990 Impact factor: 3.333

2. Identification of anthracycline analogues with enhanced cytotoxicity and lack of cross-resistance to adriamycin using a series of mammalian cell lines in vitro.

Authors: B T Hill; L Y Dennis; X T Li; R D Whelan
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333

Review 3. Developing new drugs for ovarian cancer: a challenging task in a changing reality.

Authors: R M Canetta; S K Carter
Journal: J Cancer Res Clin Oncol Date: 1984 Impact factor: 4.553

4. Phase II study of esorubicin (4'deoxydoxorubicin) in anthracycline naive patients with ovarian cancer.

Authors: M D Green; J L Speyer; J C Wernz; N Colombo; U Beller; F M Muggia; E M Beckman
Journal: Invest New Drugs Date: 1990-08 Impact factor: 3.850

5. Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced epithelial carcinoma of the ovary: a Gynecologic Oncology Group study.

Authors: W P McGuire; J A Blessing; M L Berman
Journal: Invest New Drugs Date: 1989-11 Impact factor: 3.850

6. Chemotherapy of ovarian cancer directed by the human tumor stem cell assay.

Authors: D S Alberts; H S Chen; S E Salmon; E A Surwit; L Young; T E Moon; F L Meyskens
Journal: Cancer Chemother Pharmacol Date: 1981 Impact factor: 3.333

7. Pegylated liposomal doxorubicin/carboplatin combination in ovarian cancer, progressing on single-agent pegylated liposomal doxorubicin.

Authors: Tal Grenader; Ora Rosengarten; Rut Isacson; Yevgeni Plotkin; Alberto Gabizon
Journal: World J Clin Oncol Date: 2012-10-10

8. Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.

Authors:
Journal: BMJ Date: 1991-10-12

9. The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer.

Authors: M H Bronchud; A Howell; D Crowther; P Hopwood; L Souza; T M Dexter
Journal: Br J Cancer Date: 1989-07 Impact factor: 7.640

Review 10. Implications of an overview of chemotherapy in advanced ovarian carcinoma.

Authors: C J Williams
Journal: Br J Cancer Date: 1992-08 Impact factor: 7.640